{"product_id":"2024-update-in-hematology-and-medical-oncology","title":"2024 Update in Hematology and Medical Oncology — On Demand","description":"\u003cdiv class=\"prod-format\"\u003e\n\u003ch3 class=\"test-title\"\u003e2024 Update in Hematology and Medical Oncology — On Demand\u003c\/h3\u003e\n\u003cdiv class=\"test-title\"\u003e12th Annual Hematology and Medical Oncology Board Review: Contemporary Practice – On Demand\u003c\/div\u003e\n\u003cdiv class=\"test-description\"\u003e\n\u003ch2 class=\"activitysectionbold\"\u003eOverview\u003c\/h2\u003e\n\u003cbr\u003eThe Memorial Sloan Kettering \u003cstrong\u003e12th Annual Hematology and Medical Oncology Board Review\u003c\/strong\u003e is a four day course that provides an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures provided by expert faculty will focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, central nervous system oncology, and hematologic oncology. Ample time will be provided at the conclusion of each presentation for an \u003cstrong\u003einteractive question-and-answer session\u003c\/strong\u003e with the speakers.\u003cbr\u003e\u003cbr\u003eAttendees of this course will receive access to an \u003cstrong\u003eonline syllabus\u003c\/strong\u003e, which includes select PDFs of presentations (slides) and video recordings of the lectures.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThe target audience for this program is medical oncology professionals, including physicians, nurses, pharmacists, fellows, and residents. \u003cstrong\u003eThis course is designed to enable participants to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology.\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis course is set to be an \u003cstrong\u003eexclusively live virtual experience\u003c\/strong\u003e. Detailed Zoom access and participation instructions will be provided to registrants prior to the start of the program.\u003cbr\u003e\u003ch2 class=\"activitysectionbold\"\u003eObjectives\u003c\/h2\u003e\n\u003cbr\u003eAt the conclusion of this on demand, learners will be able to:\u003cbr\u003e\u003col\u003e\n\u003cli\u003eDefine state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.\u003c\/li\u003e\n\u003cli\u003eDiscuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice\u003c\/li\u003e\n\u003cli\u003ePrepare for ABIM examinations in medical oncology and hematology.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003ch2 class=\"activitysectionbold\"\u003eSpecialties\u003c\/h2\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cdiv\u003e\u003cstrong\u003eSyllabus – 2024 Update in Hematology and Medical Oncology\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003eFriday, March 8, 2024\u003c\/div\u003e\n\u003cdiv\u003eRelevant Financial Relationships\u003c\/div\u003e\n\u003cdiv\u003e9:00AM – 9:05AM\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eView faculty disclosures here.\u003c\/div\u003e\n\u003cdiv\u003eColon Cancer\u003c\/div\u003e\n\u003cdiv\u003e9:15AM – 10:00AM\u003c\/div\u003e\n\u003cdiv\u003eLeonard B Saltz, MD\u003c\/div\u003e\n\u003cdiv\u003eColon Cancer – Video Colon Cancer – PDF\u003c\/div\u003e\n\u003cdiv\u003eMelanoma\u003c\/div\u003e\n\u003cdiv\u003e10:00AM – 10:45AM\u003c\/div\u003e\n\u003cdiv\u003eMichael Postow, MD\u003c\/div\u003e\n\u003cdiv\u003eMelanoma – Video Melanoma – PDF\u003c\/div\u003e\n\u003cdiv\u003eProstate Cancer\u003c\/div\u003e\n\u003cdiv\u003e10:45AM – 11:30AM\u003c\/div\u003e\n\u003cdiv\u003eSusan Slovin, MD, PhD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eUpdated as of 3\/8\/24 at 10:25 am\u003c\/div\u003e\n\u003cdiv\u003eProstate Cancer – Video Prostate Cancer – PDF\u003c\/div\u003e\n\u003cdiv\u003eKidney Cancer\u003c\/div\u003e\n\u003cdiv\u003e11:30AM – 12:15PM\u003c\/div\u003e\n\u003cdiv\u003eRobert Motzer, MD\u003c\/div\u003e\n\u003cdiv\u003eKidney Cancer – Video Kidney Cancer – PDF\u003c\/div\u003e\n\u003cdiv\u003eMesothelioma\u003c\/div\u003e\n\u003cdiv\u003e12:15PM – 12:30PM\u003c\/div\u003e\n\u003cdiv\u003eMarjorie G Zauderer, MD\u003c\/div\u003e\n\u003cdiv\u003eMesothelioma – Video Mesothelioma – PDF\u003c\/div\u003e\n\u003cdiv\u003eUrothelial Cancer\u003c\/div\u003e\n\u003cdiv\u003e1:15PM – 2:00PM\u003c\/div\u003e\n\u003cdiv\u003eGopa Iyer, MD\u003c\/div\u003e\n\u003cdiv\u003eUrothelial Cancer – Video Urothelial Cancer – PDF\u003c\/div\u003e\n\u003cdiv\u003eTestis Cancer\u003c\/div\u003e\n\u003cdiv\u003e2:00PM – 2:45PM\u003c\/div\u003e\n\u003cdiv\u003eDarren Feldman, MD\u003c\/div\u003e\n\u003cdiv\u003eTestis Cancer – Video Testis Cancer – PDF\u003c\/div\u003e\n\u003cdiv\u003eUterine, Cervix, and Other GYN Cancers\u003c\/div\u003e\n\u003cdiv\u003e2:45PM – 3:30PM\u003c\/div\u003e\n\u003cdiv\u003eCarol Aghajanian, MD\u003c\/div\u003e\n\u003cdiv\u003eUterine, Cervix, and Other GYN Cancers – Video Uterine, Cervix, and Other GYN Cancers – PDF\u003c\/div\u003e\n\u003cdiv\u003eOvarian Cancer\u003c\/div\u003e\n\u003cdiv\u003e3:45PM – 4:30PM\u003c\/div\u003e\n\u003cdiv\u003eRachel Grisham, MD\u003c\/div\u003e\n\u003cdiv\u003eOvarian Cancer – Video Ovarian Cancer – PDF\u003c\/div\u003e\n\u003cdiv\u003eBreast Cancer: Surgery\u003c\/div\u003e\n\u003cdiv\u003e4:30PM – 5:00PM\u003c\/div\u003e\n\u003cdiv\u003eAnita Mamtani, MD\u003c\/div\u003e\n\u003cdiv\u003eBreast Cancer: Surgery – Video Breast Cancer: Surgery – PDF\u003c\/div\u003e\n\u003cdiv\u003eBreast Cancer: Radiation Therapy\u003c\/div\u003e\n\u003cdiv\u003e5:00PM – 5:30PM\u003c\/div\u003e\n\u003cdiv\u003eLior Braunstein, MD\u003c\/div\u003e\n\u003cdiv\u003eBreast Cancer: Radiation Therapy – Video Breast Cancer: Radiation Therapy – PDF\u003c\/div\u003e\n\u003cdiv\u003eGenetics\u003c\/div\u003e\n\u003cdiv\u003e5:30PM – 6:00PM\u003c\/div\u003e\n\u003cdiv\u003eZsofia Stadler, MD\u003c\/div\u003e\n\u003cdiv\u003eGenetics – Video Genetics – PDF\u003c\/div\u003e\n\u003cdiv\u003eSaturday, March 9, 2024\u003c\/div\u003e\n\u003cdiv\u003eSmall Cell Lung Cancer\u003c\/div\u003e\n\u003cdiv\u003e7:00AM – 7:30AM\u003c\/div\u003e\n\u003cdiv\u003eNoura Choudhury, MD, Assistant Attending\u003c\/div\u003e\n\u003cdiv\u003eSmall Cell Lung Cancer  – Video Small Cell Lung Cancer  – PDF\u003c\/div\u003e\n\u003cdiv\u003eTriple Negative Breast Cancer: (Neo)adjuvant and Metastatic\u003c\/div\u003e\n\u003cdiv\u003e7:30AM – 8:00AM\u003c\/div\u003e\n\u003cdiv\u003eRachel Sanford, MD\u003c\/div\u003e\n\u003cdiv\u003eTriple Negative Breast Cancer: (Neo)adjuvant and Metastatic – Video Triple Negative Breast Cancer: (Neo)adjuvant and Metastatic – PDF\u003c\/div\u003e\n\u003cdiv\u003eHER2 Positive Breast Cancer: (Neo)adjuvant and Metastatic\u003c\/div\u003e\n\u003cdiv\u003e8:00AM – 9:00AM\u003c\/div\u003e\n\u003cdiv\u003eChau Dang, MD\u003c\/div\u003e\n\u003cdiv\u003eHER2 Positive Breast Cancer: (Neo)adjuvant and Metastatic – Video HER2 Positive Breast Cancer: (Neo)adjuvant and Metastatic – PDF\u003c\/div\u003e\n\u003cdiv\u003eHormone Receptor Positive Breast Cancer: (Neo)adjuvant and Metastatic\u003c\/div\u003e\n\u003cdiv\u003e9:00AM – 10:00AM\u003c\/div\u003e\n\u003cdiv\u003eDevika Gajria, MD\u003c\/div\u003e\n\u003cdiv\u003eHormone Receptor Positive Breast Cancer: (Neo)adjuvant and Metastatic – Video Hormone Receptor Positive Breast Cancer: (Neo)adjuvant and Metastatic – PDF\u003c\/div\u003e\n\u003cdiv\u003eCarcinoma of Unknown Primary\u003c\/div\u003e\n\u003cdiv\u003e10:00AM – 10:45AM\u003c\/div\u003e\n\u003cdiv\u003eAnna Mary Varghese, MD\u003c\/div\u003e\n\u003cdiv\u003eCarcinoma of Unknown Primary – Video Carcinoma of Unknown Primary – PDF\u003c\/div\u003e\n\u003cdiv\u003eHepatocellular Cancer and Cholangiocarcinoma\u003c\/div\u003e\n\u003cdiv\u003e10:45AM – 11:30AM\u003c\/div\u003e\n\u003cdiv\u003eGhassan K Abou-Alfa, MD, MBA, Professor\u003c\/div\u003e\n\u003cdiv\u003eHepatocellular Cancer and Cholangiocarcinoma – Video Hepatocellular Cancer and Cholangiocarcinoma – PDF\u003c\/div\u003e\n\u003cdiv\u003ePancreatic and Neuroendocrine Cancer\u003c\/div\u003e\n\u003cdiv\u003e11:30AM – 12:15PM\u003c\/div\u003e\n\u003cdiv\u003eEileen M O’Reilly, MD\u003c\/div\u003e\n\u003cdiv\u003ePancreatic and Neuroendocrine Cancer – Video Pancreatic and Neuroendocrine Cancer – PDF\u003c\/div\u003e\n\u003cdiv\u003eNon Small Cell Lung Cancer\u003c\/div\u003e\n\u003cdiv\u003e1:00PM – 2:00PM\u003c\/div\u003e\n\u003cdiv\u003eGregory Riely, MD\u003c\/div\u003e\n\u003cdiv\u003eNon Small Cell Lung Cancer – Video Non Small Cell Lung Cancer – PDF\u003c\/div\u003e\n\u003cdiv\u003eHead \u0026amp; Neck, Thyroid, and Non-Melanoma Skin Cancer\u003c\/div\u003e\n\u003cdiv\u003e2:00PM – 3:00PM\u003c\/div\u003e\n\u003cdiv\u003eLara Dunn, MD\u003c\/div\u003e\n\u003cdiv\u003eHead \u0026amp; Neck, Thyroid, and Non-Melanoma Skin Cancer – Video Head \u0026amp; Neck, Thyroid, and Non-Melanoma Skin Cancer – PDF\u003c\/div\u003e\n\u003cdiv\u003eAnal and Rectal Cancer\u003c\/div\u003e\n\u003cdiv\u003e3:00PM – 3:30PM\u003c\/div\u003e\n\u003cdiv\u003eMichael Foote, MD\u003c\/div\u003e\n\u003cdiv\u003eAnal and Rectal Cancer – Video Anal and Rectal Cancer – PDF\u003c\/div\u003e\n\u003cdiv\u003eEsophageal and Gastric Cancer\u003c\/div\u003e\n\u003cdiv\u003e3:45PM – 4:30PM\u003c\/div\u003e\n\u003cdiv\u003eDavid Ilson, MD, PhD\u003c\/div\u003e\n\u003cdiv\u003eEsophageal and Gastric Cancer – Video Esophageal and Gastric Cancer – PDF\u003c\/div\u003e\n\u003cdiv\u003eCNS Tumors\u003c\/div\u003e\n\u003cdiv\u003e4:30PM – 5:00PM\u003c\/div\u003e\n\u003cdiv\u003eThomas Kaley, MD\u003c\/div\u003e\n\u003cdiv\u003eCNS Tumors – Video CNS Tumors – PDF\u003c\/div\u003e\n\u003cdiv\u003eSarcoma\u003c\/div\u003e\n\u003cdiv\u003e5:00PM – 5:30PM\u003c\/div\u003e\n\u003cdiv\u003eRobert G Maki, MD, PhD, FACP, FASCO\u003c\/div\u003e\n\u003cdiv\u003eSarcoma – Video Sarcoma – PDF\u003c\/div\u003e\n\u003cdiv\u003eInfectious Disease\u003c\/div\u003e\n\u003cdiv\u003e5:30PM – 6:00PM\u003c\/div\u003e\n\u003cdiv\u003eSusan Seo, MD\u003c\/div\u003e\n\u003cdiv\u003eInfectious Disease – Video Infectious Disease – PDF\u003c\/div\u003e\n\u003cdiv\u003eSunday, March 10, 2024\u003c\/div\u003e\n\u003cdiv\u003ePharmacology\u003c\/div\u003e\n\u003cdiv\u003e7:00AM – 9:00AM\u003c\/div\u003e\n\u003cdiv\u003eMrinal Gounder, MD\u003c\/div\u003e\n\u003cdiv\u003ePharmacology – Video Pharmacology – PDF\u003c\/div\u003e\n\u003cdiv\u003eAcute Myeloid Leukemia (AML)\u003c\/div\u003e\n\u003cdiv\u003e9:10AM – 9:50AM\u003c\/div\u003e\n\u003cdiv\u003eEytan Stein, MD\u003c\/div\u003e\n\u003cdiv\u003eAcute Myeloid Leukemia (AML) – Video Acute Myeloid Leukemia (AML) – PDF\u003c\/div\u003e\n\u003cdiv\u003eLow-Grade Non-Hodgkin Lymphoma (NHL)\u003c\/div\u003e\n\u003cdiv\u003e9:50AM – 10:30AM\u003c\/div\u003e\n\u003cdiv\u003eAndrew D Zelenetz, MD, PhD\u003c\/div\u003e\n\u003cdiv\u003eLow-Grade Non-Hodgkin Lymphoma (NHL)  – Video Low-Grade Non-Hodgkin Lymphoma (NHL)  – PDF\u003c\/div\u003e\n\u003cdiv\u003eChronic Lymphocytic Leukemia (CLL )and Small Lymphocytic Lymphoma (SLL)\u003c\/div\u003e\n\u003cdiv\u003e10:30AM – 11:10AM\u003c\/div\u003e\n\u003cdiv\u003eMeghan C Thompson, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eUpdated as of 3\/10\/24 at 10:15 am\u003c\/div\u003e\n\u003cdiv\u003eChronic Lymphocytic Leukemia (CLL )and  Small Lymphocytic Lymphoma (SLL) – Video Chronic Lymphocytic Leukemia (CLL )and  Small Lymphocytic Lymphoma (SLL) – PDF\u003c\/div\u003e\n\u003cdiv\u003eDiffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Burkitt Lymphoma (BL)\u003c\/div\u003e\n\u003cdiv\u003e11:10AM – 12:10PM\u003c\/div\u003e\n\u003cdiv\u003ePaul A Hamlin, MD\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eUpdated as of 3\/8\/24 at 1:50 pm\u003c\/div\u003e\n\u003cdiv\u003eDiffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Burkitt Lymphoma (BL) – Video Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Burkitt Lymphoma (BL) – PDF\u003c\/div\u003e\n\u003cdiv\u003eHodgkin Lymphoma (HL) \/ T Cell\u003c\/div\u003e\n\u003cdiv\u003e12:40PM – 1:40PM\u003c\/div\u003e\n\u003cdiv\u003eAlison Moskowitz, MD\u003c\/div\u003e\n\u003cdiv\u003eHodgkin Lymphoma (HL) \/ T Cell – Video Hodgkin Lymphoma (HL) \/ T Cell – PDF\u003c\/div\u003e\n\u003cdiv\u003eAuto\/Allo\u003c\/div\u003e\n\u003cdiv\u003e1:40PM – 2:20PM\u003c\/div\u003e\n\u003cdiv\u003eGunjan Shah, MD, MS\u003c\/div\u003e\n\u003cdiv\u003eAuto\/Allo – Video Auto\/Allo – PDF\u003c\/div\u003e\n\u003cdiv\u003eCAR T cells\u003c\/div\u003e\n\u003cdiv\u003e2:20PM – 2:50PM\u003c\/div\u003e\n\u003cdiv\u003eMichael Scordo, MD\u003c\/div\u003e\n\u003cdiv\u003eCAR T cells – Video CAR T cells – PDF\u003c\/div\u003e\n\u003cdiv\u003eAcute Lymphocytic Leukemia (ALL)\u003c\/div\u003e\n\u003cdiv\u003e2:50PM – 3:20PM\u003c\/div\u003e\n\u003cdiv\u003eJae Park, MD\u003c\/div\u003e\n\u003cdiv\u003eAcute Lymphocytic Leukemia (ALL) – Video Acute Lymphocytic Leukemia (ALL) – PDF\u003c\/div\u003e\n\u003cdiv\u003eMyeloproliferative Neoplasms (MPN)\u003c\/div\u003e\n\u003cdiv\u003e3:40PM – 4:05PM\u003c\/div\u003e\n\u003cdiv\u003eRaajit Rampal, MD, PhD\u003c\/div\u003e\n\u003cdiv\u003eMyeloproliferative Neoplasms (MPN) – Video Myeloproliferative Neoplasms (MPN) – PDF\u003c\/div\u003e\n\u003cdiv\u003eMyelodysplastic (MDS)\u003c\/div\u003e\n\u003cdiv\u003e4:05PM – 4:30PM\u003c\/div\u003e\n\u003cdiv\u003eAaron D Goldberg, MD\u003c\/div\u003e\n\u003cdiv\u003eMyelodysplastic (MDS)  – Video Myelodysplastic (MDS)  – PDF\u003c\/div\u003e\n\u003cdiv\u003eChronic Myelogenous Leukemia (CML)\u003c\/div\u003e\n\u003cdiv\u003e4:30PM – 5:00PM\u003c\/div\u003e\n\u003cdiv\u003eMichael Mauro, MD\u003c\/div\u003e\n\u003cdiv\u003eChronic Myelogenous Leukemia (CML) – Video Chronic Myelogenous Leukemia (CML) – PDF\u003c\/div\u003e\n\u003cdiv\u003eMyeloma \/ Amyloid\u003c\/div\u003e\n\u003cdiv\u003e5:00PM – 6:00PM\u003c\/div\u003e\n\u003cdiv\u003eMalin Hulcrantz, MD\u003c\/div\u003e\n\u003cdiv\u003eMyeloma \/ Amyloid – Video Myeloma \/ Amyloid – PDF\u003c\/div\u003e\n\u003cdiv\u003eMonday, March 11, 2024\u003c\/div\u003e\n\u003cdiv\u003eApproach to The Bleeding Patient\u003c\/div\u003e\n\u003cdiv\u003e8:05AM – 8:50AM\u003c\/div\u003e\n\u003cdiv\u003eRekha Parameswaran, MD\u003c\/div\u003e\n\u003cdiv\u003eApproach to The Bleeding Patient – Video Approach to The Bleeding Patient – PDF\u003c\/div\u003e\n\u003cdiv\u003eThe Role of the New Direct Oral Anticoagulants in Practice\u003c\/div\u003e\n\u003cdiv\u003e8:50AM – 9:50AM\u003c\/div\u003e\n\u003cdiv\u003eSimon Mantha, MD, MPH\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eUpdated as of 3\/11\/24 at 7:30 AM\u003c\/div\u003e\n\u003cdiv\u003eThe Role of the New Direct Oral Anticoagulants in Practice – Video The Role of the New Direct Oral Anticoagulants in Practice – PDF\u003c\/div\u003e\n\u003cdiv\u003eClotting in Cancer\u003c\/div\u003e\n\u003cdiv\u003e9:50AM – 10:30AM\u003c\/div\u003e\n\u003cdiv\u003eJeffrey Zwicker, MD\u003c\/div\u003e\n\u003cdiv\u003eClotting in Cancer – Video Clotting in Cancer – PDF\u003c\/div\u003e\n\u003cdiv\u003eThrombocytopenia, ITP, and Beyond\u003c\/div\u003e\n\u003cdiv\u003e10:30AM – 11:00AM\u003c\/div\u003e\n\u003cdiv\u003eCy R Wilkins, MD\u003c\/div\u003e\n\u003cdiv\u003eThrombocytopenia, ITP, and Beyond – Video Thrombocytopenia, ITP, and Beyond – PDF\u003c\/div\u003e\n\u003cdiv\u003eSickle Cell Disease, Thalassemia\u003c\/div\u003e\n\u003cdiv\u003e11:00AM – 12:00PM\u003c\/div\u003e\n\u003cdiv\u003eSusanna Curtis, MD, PhD\u003c\/div\u003e\n\u003cdiv\u003eSickle Cell Disease, Thalassemia – Video Sickle Cell Disease, Thalassemia – PDF\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954382835810,"sku":"MED-AMB02276","price":115.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/2024-Update-in-Hematology-and-Medical-Oncology-_E2_80_94-On-Demand.jpg?v=1779374991","url":"https:\/\/meducourse.com\/products\/2024-update-in-hematology-and-medical-oncology","provider":"Meducourse","version":"1.0","type":"link"}